PAZ320

DRUG2 trials

Sponsors

Boston Therapeutics

Conditions

Type 2 Diabetes Treated With InsulinType II Diabetes

Phase 2

Study to Evaluate the Safety and Efficacy of PAZ320 in Patients With Type 2 Diabetes

CompletedNCT02060916

Boston TherapeuticsType 2 Diabetes Treated With Insulin

Start: 2011-03-31End: 2011-08-31Updated: 2014-02-13

The Efficacy and Safety of PAZ320 on PPG and Insulin Blood Levels in Type II Diabetic Patients

WithdrawnNCT04569214

Boston TherapeuticsType II Diabetes

Start: 2012-09-30End: 2013-02-28Updated: 2020-09-29